Brief: Xvivo Q2 EBIT SEK 33.4 Million
Jul 12 (Reuters) - Xvivo Q2 net income SEK 27.2 million. * Q2 EPS SEK 0.86 * Q2 sales SEK 210.3 million vs. IBES estimate SEK 193.5 million * Q2 adjusted EBIT SEK 33.4 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength